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To facilitate the passage of echo contrast agents through
the microcirculation and the echocardiographic study of
myocardial perfusion, ultrasonic energy (sonication) was
employed to produce contrast agents consisting of rel-
atively uniform, stable and small « 10 IJ- diameter)
gaseous microbubbles suspended in liquid solutions. The
size and persistence of the microbubbles was verified by
light microscopy and an in vitro system were employed
for comparative assessment of peak echo amplitude and
echo persistence characteristics of various contrast agents.
The study indicated that although a variety of hand-
agitated and sonicated contrast agents provided satis-
factory echo intensities, sonication was clearly superior
to the hand-agitation method, becausesonicationproduced
Since the 10ItIal observations of Gramiak and Shah (1) In
1968, contrast echocardiography has been used to delineate
mtracardiac structures, assess valvular competence, dem-
onstrate mtracardiac shunts and Identify pencardial effusion
(2) Most recently, Armstrong et al (3), Meltzer et al (4)
and Tel and associates (5) from this laboratory demonstrated
the use of contrast echocardiography to visuahze left ven-
tncular myocardium and areas of myocardial underperfusion
during experimental coronary artery occlusion However,
apphcation of contrast echocardiography to quantitanve as-
sessment of myocardial perfusion 10 normal and ischermc
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smaller, more uniform and more stable microbubbles
that may be suitable for myocardial contrast echo-
cardiography.
It is concluded that of the contrast agents examined,
sonicated solutions of sorbitol (70%) and dextrose (70%)
appeared to have particular potential because of the small
sizes of the microbubbles (6 ± 2 and 8 ± 3 IJ-, respec-
tively) and their prolonged in vitro persistence. The use
of sonication to produce standardized, small and stable
microbubbles should facilitate physiologic passage of the
contrast agent through the capillary beds and allow two-
dimensional imaging of the left heart myocardium dur-
ing right-sided, aortic root, coronary sinus or intraco-
ronary contrast injections.
regions of the myocardium requires a more comprehensive
understanding of the charactenstics of contrast agents and
their effects withm the myocardial rmcrocirculanon De-
velopment of standardized echo contrast agents, such as
those contaming umformly small and stable gaseous micro-
bubbles, appears to be an Important prerequisite for further
progress In the new field of myocardial contrast echo imaging
The present report descnbes our efforts to examine and
develop a vanety of contrast agent solutions contairung rru-
crobubbles that can be produced In a pracncal and controlled
manner and would be sufficiently small and stable to readily
traverse the capillary beds Supplemental ongoing mvesn-
gations examine the newly developed agents through rm-
CroSCOpIC dynamic studies of the rmcrocirculatron, and pre-
lirnmary data on transpulmonary passage of such agents are
descnbed 10 an accompanying report (6)
Methods
Materials. We examined a vanety of echo contrast agents,
mcludmg those previously reported (7,8) The solutions ana-
lyzed included
1 Degassed tap water
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2 Dextrose 5% 10 water
3 09% NaCI
4 Renografin-76
5 Indocyanme green
6 Hydrogen peroxide
7 Carbonated saline solution
8 70% sorbitol
9 Dextrose 70% In water
10 Dextrose 50% 10 water
II Mixture-x-I I ratio 25% mannitol and 0 9% saline
solution
12 Mixture->I 1 ratio of Renografin-76 and 0 9* saline
solution
13 Mixture-s-I 1 ratio of 70% sorbitol and dextrose 5% 10
water
Methods of preparation. Hand aguation With two sy-
nnges connected by a three-way stopcock, mixtures of cer-
tam solutions were forcibly flushed back and forth approx-
imately 15 to 20 times, until sufficient agitanon was produced
A small amount of arr was Introduced into a syringe before
the flushmg to serve as a source of air for microbubble
development
Sonication The Heat Systems sonicator model W-375
with a lead zirconate-titanate electrostnctive (piezoelectnc)
crystal served as a controlled source of ultrasonic energy
Introducuon of the np of the sonicator hom into a solution
resulted10 the productionof surfaceagitationand cavitation.
which created rmcrocavines withm the liquid as a result of
the powerfulultrasomccompressionsand rarefactions After
the cavitation bubbles collapsed, Immediately on cessation
of the ultrasonic energy, a second generation of bubbles
was created from the released cavitation gas bubbles (9)
Solutionscontammgdissolvedgas (that IS, carbonatedsaline
and hydrogen peroxide) were not somcated, because large
amounts of gas bubbles were already VISibly present
Microscopic analysis. Bubble size To examme the rm-
crobubbles after preparation, one drop of the previously
prepared solution was sampled from the middle of the sy-
nnge and then rapidly placed onto a microscope slide With
a cover slip Before placing a drop of the solution on a
slide, 2 m1 of the newly prepared solution was pushed through
the stopcock to flush out any trapped air bubbles Then by
placing a single drop of a contrast agent (With a 1 ounce
cover slip) under view of a binocular Olympus CHA mi-
croscope, multiplefields were viewedat a 400 magmficanon
for I minute An eyepiece net reticle graduated 10 microns
was used to Visually determine bubble size to the nearest 2
p, by direct Visual or photographic mspecnon For each
observationperiod, a fresh solution of the agent being stud-
ied was prepared. The mode, mean and standard deviation
of the bubble size were calculated
Persistence The persistence of a contrast agent was ex-
ammed by mamtammgand view109 one drop of the contrast
agent under the microscope for 5 rrunutes The number of
rrucrobubbles was counted at the begmnmg and end of the
5 mmute penod, and multiple field observations were re-
corded for each agent Persistence, expressed as a percent,
was deterrruned by dividing the number of bubbles present
at the end of 5 minutes by the number Initially present.
Invitro system. An Invitro tube systemwasconstructed
to quantify peak Intensity and persistenceof ultrasound sig-
nals of vanous contrast agents The system employed a
reservoir filled With degassed tap water, which drained by
gravity through standard Intravenous tubmg connected to
Tygon tubing of 3/8 Inch (0.95 ern) external diameter The
gravity flow was mamtamed at 2 ccls Proximal to the In-
travenous tubing. a "Y" connector served as the site of the
mjection of vanous contrast agents Into the tube system A
10 cc plastic synnge With a I Inch (2 54 em), 20-gauge
needle was utilized for each mjection consisting of 8 cc of
a particular contrast solution The force of Injection was
standardized by USIng a carbon dioxide-powered thermo-
dilution Injector (USCIIOMB)
Ten centimeters downstream from the Injection Site, the
Tygon tubing was submerged 10 a styrofoamcontainerfilled
With degassed tap water and held In a rigid position by
means of a specially designed Lucite holder The ultrasonic
transducer (3 MHz. ATL 300) was held In a copper cradle
and focused at a distance of 7 7 ern above the Tygon tubing
In the styrofoam container The position of the transducer
and theTygon tubing sectionto be Imaged werestandardized
by fixing the distance vertically and estabhshmg umforrmty
of the A-mode and M-mode Image of the anterior and pos-
tenor walls of the tubing
For persistence studies, the Tygon tubing was cross-
clamped Just distal to the area of ultrasonic imagmg The
flow was stopped 10 the tubing system and the particular
contrast agent was injected Into the Y connector site After
every mjection, the entire system was flushed With degassed
tap water and the A-mode and M-mode Images of the an-
tenor and postenor walls of the Tygon tubing assumedtheir
control amplitudes The amplitude and gam settings on the
echo receiver unit were standardized throughout the exper-
imental process
The intensity of the echographic Image of Injected con-
trast agents 10 the flowing tube system was expressed (as
a percent) as peak amplitude on the A-mode lurrunal Image
divided by the peak amplitude of the antenor wall Signal of
the tube (Fig I) Frame by frame Visual analysis of peak
amplitudesfrom A-mode Images was measuredfrom a hard-
copy pnntout USIng a calipers (to the nearest 1/50th of an
Inch)
Persistence was evaluated by the followzng cnterta 1)
presence of lurnmal reflected echographic images, or 2)
obfuscation of the postenor wall of the Tygon tubing Per-
sistence was checked on five separate occasions dunng the
trrne that the lumen of the tube contamed reflected echo-
graphic Images or the postenor tubular wall could not be
Imaged A baseline echographic Imageconsistmgof a clear
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Figure 1. In Vitro tube system peak amplitude anal-
YSIS from an A-mode frame of a Videotape record-
mg Left, M-mode recording of the tube system
Right, A-mode recordmg
B (peak amplitude of the contrast agent in the lumen l
A (constant ampl itude of the anterior wall )
x 100
tubular lumen, and a postenor wall Image that was estab-
lished before contrast mjection served as the control
Statistics. All data are expressed as the anthmetIc mean
± standard devration The microbubble drameter measure-
ments for each group were entered Into a DEC-VAX 750
computer and analyzed USIng an analysis of vanance (AN-
OVA) model Because the vanances of the SIX groups were
not equivalent, the Brown-ForsytheANOVA was used (10)
The probability (p) value for the ANOVA was less than
o00I The sigmficance levels for differences between In-
drvidual solutions were then computed USIng the Scheffe
multiple compansons test (11)
Results
Microscopic analysis. Table I lists the microscopic
analysis data It shows that the sonicated sorbitol solution
(70%) and the sonicated dextrose solution (70%) had the
smallest mean bubble sizes and the smallest standard de-
viations. Also, the Renografin-76-salIne mixture had a sig-
rnficantly smaller mean bubble SIze and standard deviation
when sonicated than It had when It was hand-agitated The
mean microbubble diameter of each solution tested was
significantly different from that of each other solution (p <
o001), except for the sonicated solutions of dextrose so-
luuon (50%) (11 ± 5 JL) and sorbitol solution (70%) diluted
WIth dextrose 5% In water (11 ± 5 JL), dextrose solunon
(50%) (11 ± 5 JL) and Renografin-76 (10 ± 4 JL), and
sorbitol solutIon (70%) diluted WIth dextrose 5% In water
(11 ± 5 JL) and Renografin-76 (10 ± 4 JL) Because the
vanability of the microbubble SIze IS also of Interest, we
tested the vanance of bubblediameter 10 the sorbitol solution
(70%) and dextrose solutIon (70%) to determine If there
was a difference USIng both the F test and Bartlett's test
(12), the sorbitol solution (70%) was found to have a smaller
vanance than that of the dextrose solution (70%) (p < 0 001)
From these data, we concluded that sonicated sorbitol (70%)
contained smaller and more umform microbubbles than did
the dextrose solution (70%)
Figure 2 demonstrates the frequency of distnbutton of
two of the prepared agents Note that the sonicated sorbitol
solution (70%) had a smaller range of bubble SIzes than drd
the hand-agitated Renografin-76 and salme mixture
In Figure 3, the effects of dilution on bubble size and
Table 1. MICroSCOPIC Analysis
Mean Mode
Agent No (iL) (iL) Persistence (%)
Sorbitol 70% (somcated) 354 6 ± 2 4 80%
Sorbitol 70% diluted I I With
dextrose 5% 10 water (sonicated) 346 II ± 5 12 69%
Sorbitol 70% (hand-agitated) 211 23 ± 24 12 92%
Dextrose 70% (somcated) 397 8 ± 3 6 57%
Dextrose 50% (sonicated) 285 II ± 5 8 63%
Renografin-76 (sonicated) 386 10 ± 4 9 58%
Renografin-76 diluted I I with
sahne solution (sonicated) 326 13 ± 5 12 42%
Renografin-76 diluted I I With
sahne solution (hand agitated) 295 16 ± 13 16 50%
No = total number of bubbles sampled
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Figure 3. Frequency distribution of microbubble sizes With a di-
Iuuon effect In sonicated solunons a, Dextrose 70% sonicated
solution b, Dextrose 50~ somcated solution
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Figure 2. HIstograms depictmg the frequency of occurrence of
microbubble sizes using two solutions and two methods of prep-
aration a, Sorbitol 70% sonicated solution b, Renografin/sahne
hand-agitated solution
distnbution are demonstrated The sonicated dextrose so-
lunon (70%) exhibited an Increase In smaller bubbles and
a narrower range of bubble sizes as compared With the
somcated dextrose solution (50%) The mean size for the
dextrose 70% was 8 ± 3 J.L as compared With the 11 ± 5
J.L mean bubble SIZe of the dextrose 50% solution
Figure 4 demon strates the effec t oj two methods of prep-
aration of contrast agents Sorucation of the Renografin-
76-sallne mixture produced a smaller size range of micro-
bubbles (mean 13 ± 5 J.L ) as compared With a larger mean
bubble size and standard deviation (16 ± 13 J.L) In the same
solution prepared by hand agitanon
The ml( roscopu: persi stence studies (Table I ) showed
that the rmcrobubbles contained In the sorbitol (70%) so-
lution persisted over the longest time period, whereas the
rmcrobubbles contained In the diluted solutions of Reno-
grafin-76 persisted over the shortest time penod
In vitro system analysis (Table 2). Mechanical agita-
tion (eithersorncanon or hand agitation) of solutions produced
greater peak lurrunal echo amplitudes than those found In
nonagitated solutions For example, nonagirated Reno-
grafin-76 had a peak amplitude of 630 ± 50%. but With
ultrasonic agrtatron (somcation) It had a peak of 89 0 ±
6 7% Similarly, the peak amplitude for nonagitated sorbitol
70% In water was 62 4 ± 21 7%. and greater than 120%
With agitation (somcation) Note that the sorncated Reno-
grafin-76 solution produced less peak amplitude but longer
persistence than the sonicated diluted Renografin-76-saline
solution
The steady state persistence studies also showed that only
With contrast agent agnation did the In Vitro tube lununal
echo amplitude persist for any significant length of time
For example, Renografin-76, when diluted to a 1 I ratio
WIth saline solution and then either hand-agitated or SOnI-
cated, persisted In the lumen of the tube system By contrast.
WIthout mechanical aguanon, the Renografin-Zo-sahne mix-
ture failed to demonstrate any persistence time
The intraobserver variability f or repeated examtnauons
of the mtcrosc0P'C analyst s of the mean bubble size was
less than 2 J.L (which was the smallest measurement umt).
and the variability of the microscopic persistence data was
less than 10% for all agents examined The day to day
vanabihty of the microscopic analysis IS presented In Table
3 It was observed that the sonicated sorbitol 70% and Ren-
ografin-76 had less than a 2 J.L diameter vanation as assessed
by day to day examination of multiple samples by one ob-
server The vanabihty of the peak arnphtude of a contrast
agent In the In vitro tube system was based on 5 to 10
mdividual injections and expressed as standard devianons
With ranges from 3 2 to 21 7% (Table 2)
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Figure 4. Effects of somcation and hand agitation on microbubble
size and distnbution In a solution of Renografin-76 and sahne a,
Sonicated solution b, Hand-agitated solution
Discussion
Sorucation appears to be a readily applicable method of
agitation that produces small, relatively uniform and stable
microbubbles This somcation process has been used for
producing finely dispersed homogeneous tissue preparations
and emulsions (13) Sorucation utihzes ultrasonic cavrtation
to create these dispersions As a by-product of this cavitation
process, a dispersion of small nncrobubbles IS formed 10 a
solution These by-product rmcrobubbles appear to be the
source of the echo contrast effect m these solutions The
sorucanon process occurs 10 a stepwise manner This process
Will be discussed bnefly because of Its new proposed ap-
phcation 10 the field of contrast echocardiography
Phases of ultrasonic sonication. This method IS pn-
manly based on a cavitanon process that appears to include
a preinuianon phase dunng which nuclei within the hquid
(for example, a small amount of trapped air or particulate
matter, or both) are brought into the intense core of the
sound field transmitted from the hom tip of the sorucation
umt Powerful compressions and rarefactions cause these
cavities 10 the liquid to be compressed and expanded m a
cyclic manner On reachmg ItS resonant size (presummg It
IS not earned away from the core position by fluid currents
or mixing) the stage IS set for the catastrophic phase This
phase IS charactenzed by Violentoscillations of the resonant
cavity 10 the stream of Vibrational energy Cyclic collapse
and expansion of these cavities radiate penodic shock waves
10 the solution, openmg up microcavmes that are extremely
small but so plentiful that a cloudhke appearance can be
50
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Table 2. In Vitro Tube System Analysis
Peak AmplItude
(%)
Persistence
(seconds)
Ultrasoruc agitanon (somcation)
70% sorbitol
70% sorbitol (diluted to I I With dextrose 5% m water)
70% dextrose
50% dextrose
Renografin-76
Renografin-76 (diluted to I I With sahne solution)
Hand agitation
70% sorbitol
Renografin-76 (diluted to I I wah sahne solution)
Nonagitatcd
Hydrogen peroxide
Carbonated saline soluuon
Renografin-76
Renografin-76 (diluted WIth salme solution)
Mannitol 25% (diluted With dextrose 5% m water)
SalIne solution
70% sorbitol
Indocyarune green
Dextrose 5% m water
Dextrose 70%
Dextrose 50%
>120
>120
110 ± 53
liZ ± 20
89 ± 67
108 ± 47
103 ± 20
>120
79 ± 93
70 ± 70
63 ± 50
49 ± 10 5
55 ± 130
43 ± 58
62 ± 21 7
81 ± 10 5
40 ± 80
82 ± 43
82 ± 32
>180
>180
>180
>180
208 ± 62
115 ± 28
>180
>180
<I
<I
<I
<I
<I
<I
<I
<I
<I
<I
<I
JACC Vol 3, No I
January 1984 14-20
FE[NSTEIN ET AL
DEVELOPMENT AND QUANT[TATIVE ANALYSIS OF ECHO CONTRAST AGENTS
19
Table 3. Day to Day Vanabihty of the MICro~COPlc Analysis of SOnicated Microbubbles
Sample n = (bubbles)
Mean :+: Standard
Deviation
Sorbitol 700k (xorucated)
Day I
Range (iL)
I 48
2 52
3 43
4 49
5 52
6 60
7 50
Total 354
45
2 38
3 55
4 35
5 37
6 35
7 39
8 39
9 31
10 32
Total 386
Ii :+: 2
~ + ,
Ii :+: 2
~ :+: 2
Day 2
Ii :+: 2
5 :+: 2
~ + ,
Ii :+: 2
Renograhn-76 (vorucated)
Day I
9 :+: 4
X :+: ,
10 :+: :;
10 :+: .+
Day 2
10 :+: .+
12 :+: X
X :+: ,
9 :+: ,
X :+: 3
II :+: :;
10 :+: .+
2 to 10
2 to 8
2 to 8
2 to [0
2 to [2
2 to 8
2 to 12
2 to 12
4 to 25
4 to 12
4 to 24
4 to 20
4 to 20
4 to 32
4to 14
4to [6
4 to 20
4 to 20
4 to 25
noted m the solution The next phase. the bubble phase,
occurs simultaneously With the catastrophic phase, that IS.
as a by-product of the catastrophic phase, noncollapsmg
bubbles are created outside of the core of the energy beam
In soluttons that are degassed or subject to reduced atmo-
sphene pressures, no secondary rmcrobubbles will be gen-
erated Finally, a postcavuation phase occurs 10 those so-
lutions that have sufficient nuclei present to support the
preceding noncollapsmg by-product microbubbles that re-
main 10 the solution after the ultrasonic energy I" turned
off
Evaluation of various contrast solutions. Our appli-
cation of ultrasonic energy (somcation) to a liquid solution
showed that the rmcrobubbles created m the VI~COU" solu-
nons such as sorbitol (70%) and dextrose (70%) were less
than IO IL m diameter (6 ± 2 and 8 ± 3 IL, respectively)
The more diluted, less VISCOUS solutions contained larger
microbubbles rang109 m size from IO to 23 IL when soru-
cated In the solutions prepared by both somcanon and hand
agitation techniques, rrucrobubbles were sigmficantly smaller
and more umtorrn when produced by somcation We are
now exammmg the physicochemical properties of the con-
trast agents to Identify optimal solutions that will support
or stabihze small rrucrobubbles
The m vitro tube studies corroborated that peak echo
amplitudes and persistence of the vanous contrast solutions
were enhanced If they were agitated, either by hand or by
somcanon, when compared With the respective nonagitated
solution (14) It IS likely that the introduction of rmcrobub-
bles of arr into the solutions produced the enhanced ultra-
~OnIC effects These findmgs are also consistent With earlier
reported observations (7.8)
Limitations and advantages. Apphcanon of m Vitro
studies to In VIVO situations may be hrruted to the extent
that temperature, pressure, blood flow and tissue charac-
tenstics may alter microbubble size and stabihty In addi-
tion, bubble size and stability may be altered by changes in
temperature of the hquid dunng the somcanon procedure,
the temperature of the microscopic stage, the length of the
observation penod and the method of standardizmg the tech-
mque for somcatmg the agents
Despite these hrmtanons, our prehrnmary m VIVO direct
visuahzatron mvestrgations us109 the baSIC cat microcircu-
lation preparation (15) With the new sonicated echo contrast
agents provided prormsmg evidence support109 the annci-
pated Importance of the smaller size of the rmcrobubbles
The small microbubbles (mean size 8 ± 3 IL) contained m
a dextrose solution (70%) readily passed through the cat
capillary rmcrovessels, whereas the larger rrucrobubbles
contained in a hand-agitated, Renografin-Zo-salme echo con-
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trast mixture (mean size 16 ± 13 JJ-) clearly caused occlu-
sion of the microvessels and evident stoppage of mdividual
microvascular flow Furthermore, our prehmmary expen-
ments with direct mtracoronary mjecnons of vanous echo
contrast agents m dogs have demonstrated myocardial con-
trast washout rates that appear to be physiologic and sig-
rnficantly shorter m duration for solutions contaimng the
sonicated. small rmcrobubbles than the prolonged disap-
pearance rates of 23 ± 6 seconds noted with solutions
contammg the larger rmcrobubbles obtamed using the hand-
agitation method (16)
In the past, the left heart structures could not be con-
sistently visualized using nght heart mjecnon sites because
of microbubble mstabihty and relatively larger sizes (17)
It would appear from our mitral m Vitro studies and prelim-
mary m VIVO work that somcation provides a Simple con-
trolled method of agitation that, m certain solutions, will
produce small, relatively uniform and stable rmcrobubbles
These sonicated agents may prove useful m contrast echo-
cardiograpluc imaging of left heart structures via nght heart
mjection sites
Future applications. Recent interest in contrast echo-
cardiography has been heightened by potential applicanons
to the study of myocardial defects, and ultimately to the
quannfication of myocardial perfusion (3-5) Prehmmary
mdications are that adequate vrdeodensitometnc methods
(18) and indexes denved by computer algonthms (16) can
now be utilized for expenmental assessment of myocardial
contrast echocardiographic measurement of regional myo-
cardial perfusion or underperfusion, m a manner analogous
to methods using nuclear imagmg
We mtroduced somcation as a new method generating a
narrow range of small « 10 JJ- diameter) rmcrobubbles We
now anticipate that It Will be possible to produce, in a
standardized manner, small and persistent contrast agent
rmcrobubbles capable of passing through the microvascu-
lature, perrruttmg echocardiographic visualization of the left
ventncular myocardium, preferably from a nght heart or
coronary sinus mjecnon site Thus, assummg that future
research Will demonstrate the safety and effectivenessof the
new small rrucrobubble-contammg contrast agents, It IS an-
ticipated that an Important new echocardrographrc method
Will become available for dynamic Simultaneous measure-
ment of regional myocardial contractile funcnon as well as
perfusion
We thank Linda Maiman Femstein and Veda Daggett tor their editonal
assistance, as well as Morgan E Stewart for her help m prepanng the
statistical analysis
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